5
Participants
Start Date
May 31, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
efalizumab
Administration of a test dose of efalizumab 0.7mg/kg will be administered at enrollment. Weekly subcutaneous injections of efalizumab 1mg/kg will begin with study visit 2 and continue for 1 year for this pilot study.
Emory University, Atlanta
Collaborators (1)
Genentech, Inc.
INDUSTRY
Emory University
OTHER